Phenotypic vs. genetic mismatch of BMI and type 2 diabetes: evidence from two perspective cohort studies

Little is known about the population-based mismatch between phenotypic and genetic BMI (BMI-PGM) and its association with type 2 diabetes. We therefore used data from the China Kadoorie Biobank and UK Biobank and calculated BMI-PGM for each participant as the difference between the percentile for ad...

Full description

Bibliographic Details
Main Authors: Li, A, Gong, S, Yu, C, Pei, P, Yang, L, Millwood, IY, Walters, RG, Chen, Y, Du, H, Yang, X, Hou, W, Chen, J, Chen, Z, Lv, J, Li, L, Sun, D, China Kadoorie Biobank Collaborative Group
Format: Journal article
Language:English
Published: American Diabetes Association 2024
_version_ 1824459256833769472
author Li, A
Gong, S
Yu, C
Pei, P
Yang, L
Millwood, IY
Walters, RG
Chen, Y
Du, H
Yang, X
Hou, W
Chen, J
Chen, Z
Lv, J
Li, L
Sun, D
China Kadoorie Biobank Collaborative Group
author_facet Li, A
Gong, S
Yu, C
Pei, P
Yang, L
Millwood, IY
Walters, RG
Chen, Y
Du, H
Yang, X
Hou, W
Chen, J
Chen, Z
Lv, J
Li, L
Sun, D
China Kadoorie Biobank Collaborative Group
author_sort Li, A
collection OXFORD
description Little is known about the population-based mismatch between phenotypic and genetic BMI (BMI-PGM) and its association with type 2 diabetes. We therefore used data from the China Kadoorie Biobank and UK Biobank and calculated BMI-PGM for each participant as the difference between the percentile for adjusted BMI at baseline and the percentile for adjusted polygenic risk score for BMI. Participants were categorized into discordantly low (BMI-PGM< the 1st quartile), concordant (the 1st quartile ≤BMI-PGM< the 3rd quartile), and discordantly high (BMI-PGM≥the 3rd quartile) groups. We calculated adjusted hazard ratios (aHRs) for the association of BMI-PGM and type 2 diabetes using Cox proportional hazard models in each cohort, and combined HRs using random-effects meta-analyses. During a median follow-up of 12 years for both cohorts, BMI-PGM was associated with the risk of type 2 diabetes, with the discordantly low group showing reduced risk and the discordantly high group showing elevated risk compared to the concordant group, independent of BMI and other conventional risk factors. In addition, normal-weight individuals with discordantly high BMIPGM faced a higher risk of type 2 diabetes than overweight individuals. These findings suggest that BMI-PGM may play a potential role in reassessing the risk of type 2 diabetes, particularly among normal-weight populations.
first_indexed 2025-02-19T04:38:54Z
format Journal article
id oxford-uuid:0aba57e6-e03e-46af-9fb3-e8308928ced6
institution University of Oxford
language English
last_indexed 2025-02-19T04:38:54Z
publishDate 2024
publisher American Diabetes Association
record_format dspace
spelling oxford-uuid:0aba57e6-e03e-46af-9fb3-e8308928ced62025-02-18T11:58:20ZPhenotypic vs. genetic mismatch of BMI and type 2 diabetes: evidence from two perspective cohort studiesJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:0aba57e6-e03e-46af-9fb3-e8308928ced6EnglishSymplectic ElementsAmerican Diabetes Association2024Li, AGong, SYu, CPei, PYang, LMillwood, IYWalters, RGChen, YDu, HYang, XHou, WChen, JChen, ZLv, JLi, LSun, DChina Kadoorie Biobank Collaborative GroupLittle is known about the population-based mismatch between phenotypic and genetic BMI (BMI-PGM) and its association with type 2 diabetes. We therefore used data from the China Kadoorie Biobank and UK Biobank and calculated BMI-PGM for each participant as the difference between the percentile for adjusted BMI at baseline and the percentile for adjusted polygenic risk score for BMI. Participants were categorized into discordantly low (BMI-PGM< the 1st quartile), concordant (the 1st quartile ≤BMI-PGM< the 3rd quartile), and discordantly high (BMI-PGM≥the 3rd quartile) groups. We calculated adjusted hazard ratios (aHRs) for the association of BMI-PGM and type 2 diabetes using Cox proportional hazard models in each cohort, and combined HRs using random-effects meta-analyses. During a median follow-up of 12 years for both cohorts, BMI-PGM was associated with the risk of type 2 diabetes, with the discordantly low group showing reduced risk and the discordantly high group showing elevated risk compared to the concordant group, independent of BMI and other conventional risk factors. In addition, normal-weight individuals with discordantly high BMIPGM faced a higher risk of type 2 diabetes than overweight individuals. These findings suggest that BMI-PGM may play a potential role in reassessing the risk of type 2 diabetes, particularly among normal-weight populations.
spellingShingle Li, A
Gong, S
Yu, C
Pei, P
Yang, L
Millwood, IY
Walters, RG
Chen, Y
Du, H
Yang, X
Hou, W
Chen, J
Chen, Z
Lv, J
Li, L
Sun, D
China Kadoorie Biobank Collaborative Group
Phenotypic vs. genetic mismatch of BMI and type 2 diabetes: evidence from two perspective cohort studies
title Phenotypic vs. genetic mismatch of BMI and type 2 diabetes: evidence from two perspective cohort studies
title_full Phenotypic vs. genetic mismatch of BMI and type 2 diabetes: evidence from two perspective cohort studies
title_fullStr Phenotypic vs. genetic mismatch of BMI and type 2 diabetes: evidence from two perspective cohort studies
title_full_unstemmed Phenotypic vs. genetic mismatch of BMI and type 2 diabetes: evidence from two perspective cohort studies
title_short Phenotypic vs. genetic mismatch of BMI and type 2 diabetes: evidence from two perspective cohort studies
title_sort phenotypic vs genetic mismatch of bmi and type 2 diabetes evidence from two perspective cohort studies
work_keys_str_mv AT lia phenotypicvsgeneticmismatchofbmiandtype2diabetesevidencefromtwoperspectivecohortstudies
AT gongs phenotypicvsgeneticmismatchofbmiandtype2diabetesevidencefromtwoperspectivecohortstudies
AT yuc phenotypicvsgeneticmismatchofbmiandtype2diabetesevidencefromtwoperspectivecohortstudies
AT peip phenotypicvsgeneticmismatchofbmiandtype2diabetesevidencefromtwoperspectivecohortstudies
AT yangl phenotypicvsgeneticmismatchofbmiandtype2diabetesevidencefromtwoperspectivecohortstudies
AT millwoodiy phenotypicvsgeneticmismatchofbmiandtype2diabetesevidencefromtwoperspectivecohortstudies
AT waltersrg phenotypicvsgeneticmismatchofbmiandtype2diabetesevidencefromtwoperspectivecohortstudies
AT cheny phenotypicvsgeneticmismatchofbmiandtype2diabetesevidencefromtwoperspectivecohortstudies
AT duh phenotypicvsgeneticmismatchofbmiandtype2diabetesevidencefromtwoperspectivecohortstudies
AT yangx phenotypicvsgeneticmismatchofbmiandtype2diabetesevidencefromtwoperspectivecohortstudies
AT houw phenotypicvsgeneticmismatchofbmiandtype2diabetesevidencefromtwoperspectivecohortstudies
AT chenj phenotypicvsgeneticmismatchofbmiandtype2diabetesevidencefromtwoperspectivecohortstudies
AT chenz phenotypicvsgeneticmismatchofbmiandtype2diabetesevidencefromtwoperspectivecohortstudies
AT lvj phenotypicvsgeneticmismatchofbmiandtype2diabetesevidencefromtwoperspectivecohortstudies
AT lil phenotypicvsgeneticmismatchofbmiandtype2diabetesevidencefromtwoperspectivecohortstudies
AT sund phenotypicvsgeneticmismatchofbmiandtype2diabetesevidencefromtwoperspectivecohortstudies
AT chinakadooriebiobankcollaborativegroup phenotypicvsgeneticmismatchofbmiandtype2diabetesevidencefromtwoperspectivecohortstudies